Search

everythinglearnresearchcommunity

for

Search:↓

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Impatiens plants have health-promoting compounds and are used for natural food coloring, but more research is needed to understand their full benefits.

Scalp cooling devices need to be powerful enough to overcome heat loss and reach the right temperature to prevent hair loss from chemotherapy.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Traditional medicinal plants are still widely used and could help local development and inter-ethnic relationships.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Finasteride effectively treats baldness but may cause sexual side effects.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

No treatment fully prevents hair loss from chemotherapy yet.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.